Revvity Gains FDA Approval for Enhanced Automated Latent Tuberculosis Test
Revvity, Inc. (NYSE: RVTY) has announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Auto-Pure 2400 liquid handling platform in combination with the T-SPOT.TB test.…
Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer
Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer Endeavor BioMedicines, a clinical-stage biotechnology company dedicated to developing groundbreaking treatments for life-threatening diseases, has announced the appointment…
Thermo Fisher Unveils Krios 5 Cryo-TEM for Enhanced Automation & Performance
Thermo Fisher Unveils Krios 5 Cryo-TEM for Enhanced Automation & Performance Thermo Fisher Scientific, a global leader in scientific innovation, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM, a cutting-edge,…
J&J Finalizes Intra-Cellular Therapies Acquisition, Strengthens Neuroscience Leadership
J&J Finalizes Intra-Cellular Therapies Acquisition, Strengthens Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., marking a significant expansion of its neuroscience portfolio.…
Columbus Unites to Support Life-Saving Research and Patient Care at the 2025 Susan G. Komen Race for the Cure
Columbus Unites to Support Life-Saving Research and Patient Care at the 2025 Susan G. Komen Race for the Cure Susan G. Komen®, the world’s leading breast cancer organization, has announced…
Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development
Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development The “Personalized Cancer Vaccine Market Opportunity & Clinical Trials Outlook 2025″ report, now available from ResearchAndMarkets.com,…
Neurogene Publishes Study on NGN-401 Gene Therapy for Rett Syndrome
Neurogene Publishes Study on NGN-401 Gene Therapy for Rett Syndrome Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company dedicated to developing transformative genetic medicines for patients suffering from rare neurological…
AGC Biologics Launches New Cell & Gene Technology Division
AGC Biologics Launches New Cell & Gene Technology Division AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the launch of its new Cell and Gene Technology…
Parse Biosciences Announces Partnership with Japanese Distributor SCRUM Inc.
Parse Biosciences Announces Partnership with Japanese Distributor SCRUM Inc. Parse Biosciences, a leading provider of scalable and accessible single-cell sequencing solutions, has announced a strategic partnership with Tokyo-based SCRUM Inc.…
Amneal Launches BORUZU, Ready-to-Use Bortezomib Injection
Amneal Launches BORUZU, Ready-to-Use Bortezomib Injection Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”), a global biopharmaceutical company, and Shilpa Medicare Limited (“Shilpa”) have officially announced the U.S. launch of BORUZU™,…
RenovoRx Announces First RenovoCath Revenues & Phase III Trial Update
RenovoRx Announces First RenovoCath Revenues & Phase III Trial Update RenovoRx, Inc. (Nasdaq: RNXT), a leading life sciences company focused on developing innovative targeted oncology therapies, has announced its financial…
AustinPx Introduces KinetiSol Equipment Leasing Program
AustinPx Introduces KinetiSol™ Equipment Leasing Program AustinPx, a leading contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally administered small molecule drugs, has announced the launch of…